Ho P L, Chan K N, Ip M S, Lam W K, Ho C S, Yuen K Y, Tsang K W
University Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Chest. 1998 Dec;114(6):1594-8. doi: 10.1378/chest.114.6.1594.
To investigate the effect of Pseudomonas aeruginosa infection on clinical parameters in Chinese patients with noncystic fibrosis and steady-state bronchiectasis.
Prospective, cross-sectional clinicomicrobiological study with informed consent.
Consecutive outpatient recruitment from a specialist bronchiectasis respiratory clinic.
Outpatients (n = 100; 62 women; 55.1+/-16.7 years old; FEV1/FVC 1.4+/-0.7/2.1+/-0.9 L), who had stable respiratory symptoms for more than 3 weeks.
Respiratory pathogens isolated from the sputum were: Pseudomonas aeruginosa (33), Haemophilus influenzae (10), Moraxella catarrhalis (2), other Gram-negative bacilli (5), Streptococcus pneumoniae (6), Staphylococcus aureus (5), mycobacteria (3), and yeast (1). Clinical parameters in patients with positive isolation of P aeruginosa were compared with those without the organism in the sputum culture (non-P aeruginosa). In the P aeruginosa group, the FEV1/FVC ratio and sputum volume were lower (p < 0.005) and higher (p < 0.0001), respectively, than those of the non-P aeruginosa group. The FEV1/FVC ratio (< 60%) and sputum volume (grading > 5) were independently associated with a positive sputum isolation of P aeruginosa with odds ratios of 3.1 (confidence interval [CI] 1.2 to 8.4; p < 0.01) and 4.7 (CI 1.6 to 13.3; p < 0.001), respectively.
P aeruginosa is the predominant respiratory pathogen isolated in the sputum of Chinese patients with steady-state bronchiectasis, and its isolation is associated with high sputum output (> or = 75th quartile) and moderately severe airflow obstruction (FEV1/FVC < 60%).
探讨铜绿假单胞菌感染对中国非囊性纤维化且处于稳定期支气管扩张患者临床参数的影响。
一项经知情同意的前瞻性横断面临床微生物学研究。
从一家支气管扩张专科呼吸诊所连续招募门诊患者。
门诊患者(n = 100;62名女性;年龄55.1±16.7岁;第一秒用力呼气容积/用力肺活量为1.4±0.7/2.1±0.9升),其呼吸道症状稳定超过3周。
从痰液中分离出的呼吸道病原体有:铜绿假单胞菌(33例)、流感嗜血杆菌(10例)、卡他莫拉菌(2例)、其他革兰氏阴性杆菌(5例)、肺炎链球菌(6例)、金黄色葡萄球菌(5例)、分枝杆菌(3例)和酵母菌(1例)。将铜绿假单胞菌分离阳性患者的临床参数与痰液培养中未检出该菌的患者(非铜绿假单胞菌感染患者)进行比较。在铜绿假单胞菌感染组中,第一秒用力呼气容积/用力肺活量比值低于非铜绿假单胞菌感染组(p < 0.005),而痰液量高于非铜绿假单胞菌感染组(p < 0.0001)。第一秒用力呼气容积/用力肺活量比值(< 60%)和痰液量(分级> 5)与痰液中铜绿假单胞菌分离阳性独立相关,优势比分别为3.1(置信区间[CI] 1.2至8.4;p < 0.01)和4.7(CI 1.6至13.3;p < 0.001)。
铜绿假单胞菌是中国处于稳定期支气管扩张患者痰液中分离出的主要呼吸道病原体,其检出与高痰液量(≥第75四分位数)和中度严重气流阻塞(第一秒用力呼气容积/用力肺活量< 60%)相关。